Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor
| Image |  |
|---|---|
| Description | scientific article published on 24 June 2020 |
| Author/s |
author: Helen M. Colhoun Sarah H Wild Naveed Sattar Robert S Lindsay Rory J. McCrimmon Sam Philip |
| Publication date | June 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |